Sort
40,608 grants matching “prostate cancer”
Integrated Translational Genoproteomics Center at Washington University
$599,999David G Mutch · Washington University · U10 · FY2014 · CA
Impact of WTC dust on immune functions and prostate cancer promotion
$599,999Stuart A Aaronson · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · OH
The Pacific Northwest Prostate Cancer SPORE
$599,996Peter S Nelson · Fred Hutchinson Cancer Research Center · P50 · FY2012 · CA
Spectroscopic dye localization: sentinel lymph nodes
$599,958Spectros Corporation · R44 · FY2002 · CA
BRAIN TUMOR SPORE GRANT
$599,883Mitchel S. Berger · University Of California, San Francisco · P50 · FY2012 · CA
A novel AR degrader in castrate-resistant prostate cancer
$599,844Hyeong-Reh Choi Kim · Wayne State University · R01 · FY2025 · CA
The Brooklyn Minority-Based Community Clinical Oncology Program
$599,843William Barney Solomon · Suny Downstate Medical Center · U10 · FY2012 · CA
Validating and Extending the PROMIS Sexual Function Measure for Clinical Research
$599,815Kevin P Weinfurt · Duke University · U01 · FY2012 · AR
TRNA AS A NOVEL TARGET FOR PROSTATE CANCER THERAPY
$599,750Trustees Of The University Of Pennsylvania, The · · FY2013 · Department of Defense
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA
$599,741Agata A Exner · Case Western Reserve University · R01 · FY2018 · EB
COOPERATIVITY BETWEEN ONCOGENIC PKC EPSILON AND PTEN LOSS IN PROSTATE CANCER PROGRESSION
$599,715Trustees Of The University Of Pennsylvania, The · · FY2014 · Department of the Army
Helicobacter pylori protein-specific antibodies and colorectal cancer risk
$599,678Meira Epplein · Vanderbilt University Medical Center · R01 · FY2016 · CA
NEW AWARD - DEPENDENT METASTASIS SUPPRESSION OF PROSTATE CANCER BY PROTEOGLYCAN SIGNALING...EFFECTIVE DATE 1 SEP 2020, DATE SIGNED 27-MAY-2020, DISTRIBUTED JUNE 1, 2020, FAADC JUNE 1, 2020
$599,625University Of Illinois · · FY2020 · Department of the Army
Rad-pathomic deep learning models to assist radiologists in differentiating aggressive from indolent prostate cancer on MRI
$599,578Mirabela Rusu · Stanford University · R37 · FY2025 · CA
Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors
$599,573Diana Zepeda-Orozco · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · CA
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials
$599,514Susan S. Eggly · Wayne State University · R01 · FY2017 · CA
Functional assessment of genes and common genetic risk variants in ovarian cancer
$599,443Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2011 · CA
Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
$599,410Amit Singal · Ut Southwestern Medical Center · R01 · FY2021 · CA
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
$599,360Alison P Klein · Johns Hopkins University · R01 · FY2012 · CA
Tissue Array Research Program
$599,322Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
THE MYC-REGULATED LONG NONCODING RNA DANCR IN PROSTATE CANCER
$599,240Trustees Of The University Of Pennsylvania, The · · FY2015 · Department of the Army
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
$599,202Simon Andrew Gayther · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Small Animal Irradiator with Cone Beam CT
$599,155Ross B Mikkelsen · Virginia Commonwealth University · S10 · FY2011 · RR
Synthesis of Antiinfective Agents
$598,892Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER
$598,804Pacific Health Research Institute · N01 · FY2000 · CN